Early Detection for Pancreatic Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to find better ways to detect pancreatic cancer early, particularly in individuals at higher risk. Participants will provide blood samples, answer questions, have their medical records reviewed, and may undergo a procedure to collect fluid from pancreatic cysts. Ideal candidates include those with a family history of pancreatic cancer, certain genetic mutations, or specific types of concerning pancreatic cysts.
As an unphased study, this trial offers participants the chance to contribute to groundbreaking research that could lead to earlier detection methods for pancreatic cancer.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to enhance early detection of pancreatic cancer, a notoriously tough-to-diagnose disease. Unlike conventional diagnostic methods, which often rely on imaging and biopsy, this study focuses on collecting blood samples and pancreatic cyst fluid during standard endoscopic procedures. This approach could lead to more accurate, less invasive, and earlier detection of pancreatic abnormalities. By improving early diagnosis, the trial could pave the way for more timely and effective intervention, potentially improving patient outcomes.
Who Is on the Research Team?
Ann L. Oberg, PhD
Principal Investigator
Mayo Clinic in Rochester
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Develop a biobank of biospecimens and data of subjects without pancreatic cancer who are at high risk
Longitudinal Follow-up
Participants are followed longitudinally to collect biospecimens and follow-up data and record medical outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Non-Interventional Study
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants undergo blood sample collection, complete questionnaires, have their medical records reviewed and undergo pancreatic cyst fluid collection during standard of care endoscopic ultrasounds fine needle aspiration.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.